Indian J Endocrinol Metab. A physical examination was performed, including body mass index, waist circumference, and hair distribution. As can be expected, cases of cardiovascular complications of transsexuals have been reported in the literature, but it is not warranted to generalize them to the whole population of transsexuals.
Demos Medical Publishing. Download as PDF Printable version. Low numbers of endocrine-related cancers have been observed in male-to-female transsexuals. Email alerts Article activity alert.
This form of hormone therapy is given as one of two types, based on whether the goal of treatment is feminization or masculinization :. Pathophysiology - E-Book. Mixed mechanism of action: Danazol Gestrinone Androstenedione immunogens: Androvax androstenedione albumin Ovandrotone albumin Fecundin.
Eur J Surg Oncol. The Journal of Urology.
Permissions Icon Permissions. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene. NS, Not significant. The FMT group experienced a significant fall in HOMA-IR after 1 yr of treatment with testosterone, which does not agree with the suggestion that an increase in testosterone in healthy women causes hyperinsulinemia and insulin resistance Views Read Edit View history.
J Clin Endocrinol Metab 50 : —
An epidemiological and demographic study of transsexuals in The Netherlands. Presurgical adjustment in male transsexuals with and without hormonal treatment. The distribution of adipose fat tissue changes slowly over months and years.
There are two reports of M2F who developed breast carcinomas while receiving estrogen treatment 22 , Goodwin WE , Cummings RH Squamous metaplasia of the verumontanum with obstruction due to hypertrophy: long-term effects of estrogen on the prostate in an aging male-to-female transsexual.
A review concluded that hormone therapy for transgender people is safe when supervised by a qualified medical professional.